• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大自然的化学对健康、社会和经济的非凡益处。

The Extraordinary Benefit of Nature's Chemistry to Health, Society, and the Economy.

作者信息

Moore Bradley S, Newman David J

机构信息

Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, California 92093-0204, United States.

Skaggs School of Pharmacy and Pharmaceutical Sciences, 92093-0204, La Jolla, California 92093-0204, United States.

出版信息

J Nat Prod. 2025 Jun 27;88(6):1541-1548. doi: 10.1021/acs.jnatprod.5c00554. Epub 2025 Jun 12.

DOI:10.1021/acs.jnatprod.5c00554
PMID:40503949
Abstract

The connection between humans and Nature's chemistry is astonishing and built into the very fabric of our genetic code. In this Perspective, we focus on bioactive molecules from microbes, plants, and animals that transformed our health and society and continue to change the course of human history. In light of our changing planet and recent public distrust in science, our intimate connection with Nature and its solutions to our problems are in peril. It has never been more important to invest new effort into understanding the mysteries of life's molecules to preserve our own existence.

摘要

人类与大自然的化学之间的联系令人惊叹,并且深深嵌入我们遗传密码的结构之中。在这篇视角文章中,我们聚焦于来自微生物、植物和动物的生物活性分子,这些分子改变了我们的健康和社会,并持续影响着人类历史的进程。鉴于我们不断变化的星球以及近期公众对科学的不信任,我们与大自然的紧密联系以及大自然为我们问题提供的解决方案正处于危险之中。投入新的努力去理解生命分子的奥秘以维护我们自身的生存,从未像现在这样重要。

相似文献

1
The Extraordinary Benefit of Nature's Chemistry to Health, Society, and the Economy.大自然的化学对健康、社会和经济的非凡益处。
J Nat Prod. 2025 Jun 27;88(6):1541-1548. doi: 10.1021/acs.jnatprod.5c00554. Epub 2025 Jun 12.
2
The Lived Experience of Autistic Adults in Employment: A Systematic Search and Synthesis.成年自闭症患者的就业生活经历:系统检索与综述
Autism Adulthood. 2024 Dec 2;6(4):495-509. doi: 10.1089/aut.2022.0114. eCollection 2024 Dec.
3
An Occupational Science Contribution to Camouflaging Scholarship: Centering Intersectional Experiences of Occupational Disruptions.职业科学对伪装学术的贡献:以职业中断的交叉经历为中心
Autism Adulthood. 2025 May 28;7(3):238-248. doi: 10.1089/aut.2023.0070. eCollection 2025 Jun.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
Pharmacological treatment of children with gastro-oesophageal reflux.胃食管反流患儿的药物治疗
Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD008550. doi: 10.1002/14651858.CD008550.pub2.
6
Developmental language disorder and neurodiversity: Surfacing contradictions, tensions and unanswered questions.发展性语言障碍与神经多样性:揭示矛盾、紧张关系和未解决的问题。
Int J Lang Commun Disord. 2024 Jul-Aug;59(4):1505-1516. doi: 10.1111/1460-6984.13009. Epub 2024 Jan 26.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Fabricating mice and dementia: opening up relations in multi-species research制造小鼠与痴呆症:开启多物种研究中的关联
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Exploring nature's battlefield: organismic interactions in the discovery of bioactive natural products.探索自然的战场:生物活性天然产物发现中的机体相互作用。
Nat Prod Rep. 2024 Nov 13;41(11):1630-1651. doi: 10.1039/d4np00018h.

引用本文的文献

1
Discovery, biosynthesis, and bioactivities of peptidic natural products from marine sponges and sponge-associated bacteria.来自海洋海绵及海绵共生细菌的肽类天然产物的发现、生物合成及生物活性
Nat Prod Rep. 2025 Sep 12. doi: 10.1039/d5np00048c.
2
Molecular Basis for Asynchronous Chain Elongation During Rifamycin Antibiotic Biosynthesis.利福霉素抗生素生物合成过程中异步链延伸的分子基础
bioRxiv. 2025 Jul 6:2025.07.05.663307. doi: 10.1101/2025.07.05.663307.

本文引用的文献

1
How Trump is following Project 2025's radical roadmap to defund science.特朗普如何遵循“2025计划”的激进路线图来削减对科学的资金投入。
Nature. 2025 Mar 27. doi: 10.1038/d41586-025-00780-2.
2
Artificial Intelligence in Natural Product Drug Discovery: Current Applications and Future Perspectives.天然产物药物发现中的人工智能:当前应用与未来展望。
J Med Chem. 2025 Feb 27;68(4):3948-3969. doi: 10.1021/acs.jmedchem.4c01257. Epub 2025 Feb 6.
3
Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
全球细菌对抗菌药物耐药性的负担 1990-2021:一项系统分析及对 2050 年的预测。
Lancet. 2024 Sep 28;404(10459):1199-1226. doi: 10.1016/S0140-6736(24)01867-1. Epub 2024 Sep 16.
4
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics.ESKAPE 病原体:抗微生物药物耐药性、流行病学、临床影响和治疗学。
Nat Rev Microbiol. 2024 Oct;22(10):598-616. doi: 10.1038/s41579-024-01054-w. Epub 2024 Jun 3.
5
The WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation.世界卫生组织真菌优先病原体清单:重新评估以审查优先级的关键
Lancet Microbe. 2024 Jul;5(7):717-724. doi: 10.1016/S2666-5247(24)00042-9. Epub 2024 Apr 9.
6
A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers.FDA 批准的抗体药物偶联物在人类癌症中的临床疗效评价。
Mol Cancer. 2024 Mar 23;23(1):62. doi: 10.1186/s12943-024-01963-7.
7
Regulatory Considerations in the Approval of Rezafungin (Rezzayo) for the Treatment of Candidemia and Invasive Candidiasis in Adults.监管考虑因素在 Rezafungin(Rezzayo)批准成人治疗念珠菌血症和侵袭性念珠菌病。
J Infect Dis. 2024 Aug 16;230(2):505-513. doi: 10.1093/infdis/jiae146.
8
Cancer-targeting antibody-drug conjugates drive dealmaking frenzy.靶向癌症的抗体药物偶联物引发交易热潮。
Nat Biotechnol. 2024 Mar;42(3):362-366. doi: 10.1038/s41587-024-02168-5.
9
Non-Insulin-Based Drug Entities Used to Treat Diabetes Type 2 Disease (T2DM), Based on Natural Products from All Sources.基于全来源天然产物的用于治疗 2 型糖尿病(T2DM)的非胰岛素类药物实体。
J Nat Prod. 2024 Mar 22;87(3):629-637. doi: 10.1021/acs.jnatprod.3c00886. Epub 2024 Feb 16.
10
Advancements and challenges in antifungal therapeutic development.抗真菌治疗药物研发的进展与挑战。
Clin Microbiol Rev. 2024 Mar 14;37(1):e0014223. doi: 10.1128/cmr.00142-23. Epub 2024 Jan 31.